• Cardio Conferences
  • Cardio Quick Review
  • Cardio Calendar
  • Cardio Articles
  • Cardio Refresher
  • Cardio Case
  • Cardio Talks
  • Cardio ECG
  • Symposium
    Umbrella Heart FailureSymposium 1401Umbrella HypertensionUmbrella, Heart And StrokeUmbrella, CCSSymposium 1400
  • Impact: Survival difference in dyspnea and chest pain as an initial symptom of NSTEMI

    January 28, 2023

    Impact: Dyspnea vs. Chest Pain in the survival of NSTEMI patients

  • Impact: Management of ACS in older adults, an AHA statement

    December 24, 2022

    Impact: ACS in the elderly

  • Impact: single chest x-ray could predict 10-year CVD risk

    December 17, 2022

    Impact: one CXR to determine 10-yr CVD risk

  • CardioWatch, Season 2 Episode 5

    November 27, 2022

    CardioWatch S02E05

  • PANTHER: Clopidogrel overcoming the old rival

    November 27, 2022

    A quick review on PANTHER study

  • Impact: The association between dairy intake and risk of cardiovascular disease and mortality in patients with stable angina pectoris

    November 19, 2022

    Impact: Dairy consumption and cardiovascular risk

  • Impact: Experts Express Caution Over Type 2 Diabetes-Tea Drinking Claim

    November 14, 2022

    Impact: Tea consumption and DM risk

  • Impact: The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality

    November 14, 2022

    Impact: Coffee consumption and CV risk

  • Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after coronary artery bypass grafting

    November 2, 2022

    Dual antiplatelet Tx. with Ticagrelor and graft failure after CABG

  • Impact: Acetaminophen in comparison to NSAIDs in cardiovascular diseases

    October 31, 2022

    Impact: Acetaminophen vs. NSAIDs in CVD

  • Impact: Improved Likelihood of Survival With the Use of the Head-Up CPR Bundle for Non-Shockable Cardiac Arrest

    October 24, 2022

    Impact: Improved Survival With the Head-Up CPR Bundle for Non-Shockable Cardiac Arrest

  • Impact: Pulmonary Artery Denervation for Pulmonary Arterial Hypertension

    October 19, 2022

    Impact: Pulmonary Artery Denervation for PAH

  • Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrEF

    October 16, 2022

    Impact: Sacubitril/Valsartan and MR severity in HFrEF

  • Impact: Effect of statin therapy on muscle symptoms

    September 26, 2022

    Impact: Effect of statin therapy on muscle symptoms

  • CardioWatch, Season 2 Episode 4

    August 9, 2022

    CardioWatch S02E04

  • CardioWatch, Season 2 Episode 3

    June 6, 2022

    CardioWatch S02E03

  • CardioWatch, Season 2 Episode 2

    May 8, 2022

    CardioWatch S02E02

  • American College of Cardiology (ACC) congress 2022 landmark trials review

    May 3, 2022

    ACC 2022 congress coverage

  • At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS

    April 23, 2022

    Ticagrelor and secondary prevention in CCS

  • TicaHub 2: Ticagrelor in clinical trials

    April 19, 2022

    TicaHub 2

  • CardioWatch, Season 2 Episode 1

    April 4, 2022

    CardioWatch S02E01

  • Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF

    December 29, 2021

    Rivaroxaban vs Apixaban in AF

  • Antiplatelet journal scan

    October 19, 2021

    A review on recent antiplatelet therapy trials

  • Landmark trials of ESC 2021 congress

    September 29, 2021

    2021 post-ESC headlines

  • Cardio-Watch Podcast: Episode 7, ESC 2021 special

    September 20, 2021

    The seventh episode of Cardio-Watch: ESC 2021

  • Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19

    September 17, 2021

    The role of Heparin in the management of thrombosis in COVID-19

  • Cardio-Watch Podcast: Episode 6, Electrophysiology

    August 24, 2021

    The sixth episode of Cardio-Watch: Electrophysiology

  • Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI

    August 24, 2021

    Neprilysin Inhibitors to prevent LV remodeling post MI

  • Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial

    August 22, 2021

    Midodrine in vasovagal syndrome prevention

  • Long-term event-free and overall survival with Dapagliflozin in HFrEF patients

    August 21, 2021

    Impact of Dapagliflozin on the survival of HFrEF patients

  • Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial

    August 15, 2021

    Milrinone vs. Dobutamine: DOREMI trial

  • Cardio-Watch Podcast: Episode 5, cardiometabolic disorders

    July 12, 2021

    The fifth episode of Cardio-Watch: cardiometabolic disorders

  • Safety and Efficacy of different antithrombotic strategies after TAVI

    July 11, 2021

    Post-TAVI antithrombotic strategies

  • Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients

    July 5, 2021

    Diagnosis and management of Iron deficiency in HF patients

  • Cardio-Watch Podcast: Episode 4, Dyslipidemia

    June 28, 2021

    The fourth episode of Cardio-Watch: Dyslipidemia

  • Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter

    June 13, 2021

    The Third episode of Cardio-Watch: AF

  • Left Atrial Appendage Occlusion to prevent Stroke

    June 9, 2021

    Preventing Stroke by surgical LA Appendage Occlusion

  • A review on four landmark anti-platelet therapy trials

    June 1, 2021

    The latest updates on anti-platelet therapy from 4 important trials

  • Cardio-Watch podcast: Episode 2, Hypertension

    May 29, 2021

    The second episode of Cardio-Watch: Hypertension

  • Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI

    May 20, 2021

    The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)

  • Impact: DAPT vs. Aspirin in patients with stroke or TIA

    May 16, 2021

    A recent meta-analysis about antiplatelet therapy in stroke

  • Cardio-Watch Podcast: Episode one; COVID-19 and the heart

    May 15, 2021

    The first episode of Cardio-Watch podcast

  • Impact: the paradox of physical activity in cardiovascular disease

    May 2, 2021

    The contemporary Copenhagen general population study

  • Impact: No-LVT trial

    April 13, 2021

    Comparative study of oral anticoagulation in left ventricular thrombi

  • Impact: Statin treatment and muscle symptoms

    March 2, 2021

    StatinWise Trial

  • Impact: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomized, open-label trial

    January 20, 2021

    Continue vs Stop of RAS inhibitors in patients with COVID-19

  • Impact: EMPA-RESPONSE-AHF

    December 7, 2020

    Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)

  • A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)

    December 2, 2020

    A quick review on the findings of TIPS-3 trial from AHA congress 2020

  • The role of Omega 3 and Vitamin D in the Primary Prevention of AF (VITAL-RHYTHM Trial)

    December 2, 2020

    Dietary Supplements and AF

  • Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)

    December 2, 2020

    The Important findings of SCORED trial from AHA 2020 congress in brief

  • High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)

    December 2, 2020

    A quick review on the findings of INVESTED trial from AHA congress 2020

  • Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in HF (GALACTIC-HF Trial)

    December 2, 2020

    A quick review on the findings of GALACTIC-HF trial from AHA congress 2020

  • Early Coronary CT Angiography in Patients with Suspected or Provisionally Diagnosed ACS (RAPID CTCA trial)

    November 30, 2020

    Early Coronary CT-angiography in ACS

  • Rilonacept (IL-1α and β inhibitor) in the treatment of recurrent pericarditis

    November 30, 2020

    a pivotal symptomatology and outcomes study (RHAPSODY Trial)

  • Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor+ASA for Prevention of Stroke and Death (THALES Trial)

    November 30, 2020

    The effects of Ticarelor+ASA in Acute Stroke

  • Effects of Evolocumab on Complex Coronary Disease Requiring Revascularization

    November 30, 2020

    Evolocumab in the pipeline

  • Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)

    November 30, 2020

    Sotagliflozin in T2DM and exacerbated HF

  • Ticagrelor VS. Clopidogrel in elective PCI

    November 26, 2020

    The findings of ALPHEUS trial

  • Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)

    November 26, 2020

    Iron supplementation in acute heart failure

  • Rivaroxaban in Patients with AF and a Bioprosthetic Mitral Valve

    November 26, 2020

    The findings of RIVER trial

  • Cryoablation or Drug Therapy for the Initial Treatment of AF (EARLY-AF)

    November 26, 2020

    Treatment strategies of AF

  • Enhanced Monitoring for AF Following Cardiac Surgery (SEARCH-AF)

    November 26, 2020

    Detection of AF after cardiac surgery

  • Finerenone Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease (FIDELIO-DKD Trial)

    November 3, 2020

    Finerenone protecting kidneys

  • Journal Club 4th Session

    Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial

    October 20, 2020

    Monthly Case-Based Clinical Problem Solving

  • Daily Cardiology Journal Club 3rd Session

    Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial

    September 15, 2020

    Monthly Case-Based Clinical Problem Solving

  • Impact: Icosapent ethyl in elevated TG

    September 1, 2020

    The findings of EVAPORATE trial

  • Impact: Efficacy and safety of Trimetazidine after PCI

    September 1, 2020

    The findings of ATPCI trial

  • Impact: adding Ticagrelor to Aspirin in CABG patients

    September 1, 2020

    The findings of POPular CABG trial

  • Impact: Colchicine in patients with acute coronary syndrome

    September 1, 2020

    The findings of COPS trial

  • Impact: Colchicine in patients with chronic coronary syndrome

    September 1, 2020

    The findings of LoDoCo2 trial

  • Impact: Mavacamten for the treatment of symptomatic HCM

    August 31, 2020

    The findings of EXPLORER HCM trial

  • Impact: Aspirin with or without Clopidogrel after TAVI

    August 31, 2020

    The findings of POPULAR TAVI trial

  • Impact: cardiovascular and renal outcomes of Empagliflozin in HF

    August 31, 2020

    The findings of EMPEROR-REDUCED trial

  • Impact: Early rhythm control in AF

    August 31, 2020

    The findings of EAST-AFNET 4 trial

  • Impact: Intracoronary infusion of bone marrow-derived mononuclear cells in AMI

    August 31, 2020

    The findings of BAMI trial

  • Impact: Time-to-treatment of Colchicine and post-MI cardiovascular outcomes

    August 31, 2020

    The findings of COLCOT trial

  • Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial

    August 27, 2020

    Monthly Case-Based Clinical Problem Solving

  • Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?

    July 23, 2020

    Monthly Case-Based Clinical Problem Solving

  • Benefits of Targeting for a <70 mg/dL LDL Cholesterol During 5 Years After Ischemic Stroke

    March 6, 2020

    The findings of TST study

  • Electrical versus pharmacological cardioversion for acute AF in emergency settings

    March 6, 2020

    The findings of RAFF2 trial

  • Predicting the Risk of Post-stroke Atrial Cardiopathy

    February 27, 2020

    An interim analysis from ACARDIA trial

  • Dapagliflozin in concurrent Atrial Fibrillation and T2DM

    February 12, 2020

    Insights from DECLARE-TIMI 58 Trial

  • Intensive LDL lowering beyond current recommendations for MACE prevention

    February 12, 2020

    A meta-analysis of RCTs

  • OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm

    February 3, 2020

    A meta-analysis of RCTs

  • Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients

    January 21, 2020

    The findings of a recent study

  • Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease

    January 21, 2020

    A meta-analysis of RCTs

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM

    January 18, 2020

    The renal and cardiovascular protective effects of SGLT2 inhibitors

  • Intensive Blood Pressure lowering and the Concerns about Falling

    January 18, 2020

    The findings of SPRINT trial

  • Timing of Staged Non-Culprit Artery PCI in STEMI

    January 7, 2020

    The findings of COMPLETE Trial about PCI timing

  • Inclisiran for patients with ASCVD and elevated LDL

    December 2, 2019

    The findings of ORION-10 trial in ASCVD patients

  • Dapagliflozin in non-DM Patients with HF and Reduced EF

    December 2, 2019

    The findings of DAPA-HF trial in non-diabetics

  • Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL

    November 29, 2019

    The findings of ORION-9 trial about Inclisiran in HeFH

  • The Efficacy and Safety of Low-Dose Colchicine after MI

    November 29, 2019

    The findings of COLCOT trial about colchicine post-MI

  • Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome

    November 29, 2019

    The findings of ISCHEMIA trial

  • Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis

    November 29, 2019

    The findings of RECOVERY trial

  • AF after Non-Cardiac Surgery Increases the Risk of Stroke

    November 13, 2019

    A meta-analysis of post-operative AF studies

  • Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome

    November 12, 2019

    Rivaroxaban versus warfarin in APS

  • Antithrombotic treatment after CABG

    November 12, 2019

    A recent meta-analysis on post-CABG Antithrombotic therapy

  • Triglyceride Lowering and Cardiovascular Risk Reduction

    November 4, 2019

    A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs

  • Risk of Mortality Following Catheter Ablation of AF

    November 3, 2019

    Mortality risk after AF ablation

  • Bedtime hypertension treatment improves cardiovascular risk reduction

    October 29, 2019

    The findings of Hygia Chronotherapy Trial

  • Peri-operative beta-blockers in non-cardiac surgery

    October 24, 2019

    The findings of Cochrane database systematic review

  • Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

    October 15, 2019

    The findings of EXCEL Trial

  • Ticagrelor with or without Aspirin in High-Risk patients after PCI

    September 28, 2019

    The findings of TWILIGHT Trial

  • Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy

    August 28, 2019

    The findings of STICH trial

  • Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin

    August 24, 2019

    The findings of COMPASS trial

  • OAC Monotherapy in Patients with Stable CAD and Non-valvular AF

    August 20, 2019

    OACs in Stable CAD and AF

  • Acute vs Subacute Coronary Angiography in NSTEMI

    August 16, 2019

    The findings of NONSTEMI Trial

  • Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI

    August 3, 2019

    P2Y12 loading dose timing in PCI

  • Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer

    July 9, 2019

    Preventing the cardiotoxicity of Trastuzumab

  • Ezetimibe for the prevention of heart disease and death

    June 14, 2019

    The role of Ezetimibe in reducing CVD adverse outcomes

  • Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half

    May 29, 2019

    The findings of REASTART Trial

  • Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA

    May 25, 2019

    DAPT after ischemic stroke or TIA

  • Canagliflozin and Renal Outcomes in T2Dm and Nephropathy

    May 6, 2019

    The findings of CREDENCE Trial

  • Anticoagulation in HF and sinus rhythm

    April 27, 2019

    OACs in HF and sinus rhythm

  • TAVR vs SAVR: insights from ACC.19

    April 14, 2019

    The findings of PARTNER 3 and EVOLUT trials

  • Antithrombotic Therapy after ACS or PCI in AF

    April 7, 2019

    The findings of AUGUSTUS Trial

  • Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis

    March 3, 2019

    Stenting vs endarterectomy in symptomatic carotid stenosis

Follow US
  • admin@dailycardiology.ir
  • Telegram
  • Instagram
  • Contact us
  • Become a team member
Clinical Topics
    • Acute Coronary Syndrome
    • Ambulatory Blood Pressure Monitoring
    • Anticoagulation
    • Arrhythmia
    • Atrial Fibrillation
    • Cardiac Catheterization
    • Cardiac Imaging
    • Cardiac Surgery
    • Cardiometabolic Disease
    • Congenital Heart Disease
Clinical Topics
    • Coronary Angiography and Intervention
    • Deep Vein Thrombosis
    • Echocardiography
    • Electrocardiography
    • Geriatric Cardiology
    • Heart Failure
    • Hypertension
    • Infective Endocarditis
    • Noncoronary Invasive Procedures
    • Peripheral Arterial Disease
Clinical Topics
    • Pharmacotherapy
    • Prevention
    • Pulmonary Embolism
    • Pulmonary Hypertension
    • Sports and Exercise Cardiology
    • Stable ischemic Heart Disease
    • Valvular Heart Disease
    • COVID-19
    • CVD and disorders of other organs
    • Noncardiac Surgery

Copyright All rights reserved ©2021 Daily Cardiology Academy Team

Design By Tysiz